Table 1

Patient characteristics, postadmission procedures and patient outcomes

n=19 926
Patient characteristics
 Women, n (%)9884 (49.6)
 Age in years, mean±SD79.0±11.9
 Route of admission, n (%)
  Emergency with ambulance use6393 (32.1)
  Emergency without ambulance use9903 (49.7)
  Scheduled3630 (18.2)
 New York Heart Association functional class, n (%)
  Class II5796 (29.1)
  Class III7318 (36.7)
  Class IV6812 (34.2)
 Comorbidities, n (%)
  Hypertension10 588 (53.1)
  Ischaemic heart disease6120 (30.7)
  Atrial fibrillation/flutter5369 (26.9)
  Fatal arrhythmia385 (1.9)
  Shock321 (1.6)
Postadmission treatments indicating disease severity, n (%)
 Disease severity classes*
  No target treatments provided16 079 (80.7)
  Catecholamine use only3090 (15.5)
  Intubation with no catecholamine use179 (0.9)
  Intubation with catecholamine use364 (1.8)
  Intra-aortic balloon pumping†194 (1.0)
  Percutaneous cardiopulmonary support‡20 (0.1)
 Dialysis-related procedures790 (4.0)
 Blood transfusion1340 (6.7)
Other postadmission high-cost examinations and treatments, n (%)
 Percutaneous coronary intervention840 (4.2)
 Scintigraphy226 (1.1)
 Single-photon emission CT1840 (9.2)
Patient outcomes
 In-hospital mortality, n (%)1725 (8.7)
 Length of stay, days (mean; SD; median)19.9; 12.1; 17.0
 Hospitalisation costs (US$) (mean; SD; median)8284; 7448; 6473
  • *These six disease-severity classes are based on hierarchical and mutually exclusive combinations.

  • †Regardless of intubation or catecholamine use.

  • ‡Regardless of intra-aortic balloon pumping, intubation or catecholamine use.